Members are kindly invited to inform MedTech Europe if they should engage in the consultation, and if yes, share in the document at the link here, answers to the following questions:
- What are members’ views on the proposed actions for the future roadmap summarized above?
- Is there something missing?
- Is there support members require to gradually phase-out animal testing? E.g. research, funding, etc?
- Are there provisions on animal testing in MDR/IVDR that could be subject to discussion/review by the Commission in this roadmap?
- What are some key recommendations on phasing-out animal testing from members?
- Are there other points members would like to make, not addressed by the questions above?
Feedback should be provided by 7 October.
